Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Protalix BioTherapeutics Pipeline Progress
Article By:
Terry Chrisomalis
Wednesday, July 29, 2020 9:54 AM EDT
Protalix Biotherapeutics (PLX) offers great potential in the coming months as its lead candidate, PLX-102 - a therapy for Fabry disease, is edging closer to the finish line.
Market Briefing For Tuesday, April 28
Article By:
Gene Inger
Tuesday, April 28, 2020 2:47 AM EDT
We do know that every sector of S&P has firmed, and it (backed by the Fed) continues grinding higher within the target range we've had now for well over a month. That's a zone I've referred to as between the 50-DMA and 200-DMA.
Week In Review: China Resources Pharma Stages $1.8 Billion Hong Kong IPO
Article By:
ChinaBio® Today
Saturday, October 29, 2016 1:09 PM EDT
CR Pharma is China's second-largest drugmaker, with extensive holdings in drug manufacturing (both western and TCM) plus its large China drug distribution operation.
In this article: PSTI